Total Payments
$2,008
2024 Payments
$188.32
Companies
16
Transactions
31
Medicare Patients
3,084
Medicare Billing
$716,369
Payment Breakdown by Category
Food & Beverage$1,701 (84.7%)
Education$156.71 (7.8%)
Other$150.00 (7.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,701 | 26 | 84.7% |
| Education | $156.71 | 4 | 7.8% |
| Honoraria | $150.00 | 1 | 7.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Pharmacyclics LLC, An AbbVie Company | $495.25 | 7 | $0 (2023) |
| Janssen Biotech, Inc. | $227.90 | 3 | $0 (2023) |
| Celgene Corporation | $210.60 | 1 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $172.67 | 2 | $0 (2019) |
| Amgen Inc. | $161.88 | 3 | $0 (2022) |
| Karyopharm Therapeutics Inc. | $128.18 | 2 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $114.30 | 1 | $0 (2020) |
| Intuitive Surgical, Inc. | $100.30 | 1 | $0 (2018) |
| ABBVIE INC. | $99.99 | 1 | $0 (2024) |
| Genmab U.S., Inc. | $88.33 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $188.32 | 2 | ABBVIE INC. ($99.99) |
| 2023 | $184.57 | 3 | Pharmacyclics LLC, An AbbVie Company ($80.97) |
| 2022 | $315.19 | 3 | Celgene Corporation ($210.60) |
| 2021 | $228.22 | 4 | Pharmacyclics LLC, An AbbVie Company ($125.00) |
| 2020 | $317.22 | 7 | AstraZeneca Pharmaceuticals LP ($114.30) |
| 2019 | $302.42 | 5 | Alexion Pharmaceuticals, Inc. ($150.00) |
| 2018 | $240.85 | 3 | Pharmacyclics LLC, An AbbVie Company ($125.00) |
| 2017 | $231.02 | 4 | Amgen Inc. ($120.00) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $88.33 | General |
| Category: Oncology | ||||||
| 10/12/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $80.97 | General |
| Category: ONCOLOGY | ||||||
| 04/19/2023 | Janssen Biotech, Inc. | TECVAYLI (Biological) | Food and Beverage | In-kind items and services | $79.73 | General |
| Category: Oncology | ||||||
| 02/06/2023 | E.R. Squibb & Sons, L.L.C. | SPRYCEL (Drug) | Education | In-kind items and services | $23.87 | General |
| Category: Oncology | ||||||
| 11/01/2022 | Amgen Inc. | Blincyto (Biological) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Oncology | ||||||
| 09/13/2022 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $210.60 | General |
| Category: Hematology | ||||||
| 04/27/2022 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $85.67 | General |
| Category: Oncology | ||||||
| 05/19/2021 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ONCOLOGY | ||||||
| 04/28/2021 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $62.50 | General |
| Category: Oncology | ||||||
| 02/11/2021 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $27.38 | General |
| Category: Oncology | ||||||
| 01/04/2021 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Oncology | ||||||
| 12/03/2020 | GlaxoSmithKline, LLC. | BLENREP (Biological) | Food and Beverage | In-kind items and services | $31.99 | General |
| Category: ONCOLOGY | ||||||
| 11/10/2020 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $114.30 | General |
| 11/05/2020 | Amgen Inc. | Kyprolis (Drug) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: Oncology | ||||||
| 09/01/2020 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Oncology | ||||||
| 07/22/2020 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $100.80 | General |
| Category: Oncology | ||||||
| 02/25/2020 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: Oncology | ||||||
| 01/22/2020 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug), Nexavar | Food and Beverage | In-kind items and services | $11.39 | General |
| Category: Oncology | ||||||
| 12/09/2019 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: Oncology | ||||||
| 11/06/2019 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $103.87 | General |
| Category: Oncology | ||||||
| 08/07/2019 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Oncology | ||||||
| 06/27/2019 | Alexion Pharmaceuticals, Inc. | Soliris (Drug) | Honoraria | Cash or cash equivalent | $150.00 | General |
| Category: Immunology | ||||||
| 03/18/2019 | Clovis Oncology, Inc. | Rubraca (Drug) | Education | In-kind items and services | $10.18 | General |
| Category: Oncology | ||||||
| 09/25/2018 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $15.55 | General |
| Category: Hematology/Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 801 | 1,973 | $666,153 | $161,059 |
| 2022 | 9 | 798 | 2,003 | $623,956 | $166,031 |
| 2021 | 9 | 839 | 2,810 | $881,486 | $245,795 |
| 2020 | 8 | 646 | 2,099 | $640,081 | $143,484 |
Total Patients
3,084
Total Services
8,885
Medicare Billing
$716,369
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 325 | 1,135 | $346,175 | $84,909 | 24.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 114 | 310 | $120,590 | $33,740 | 28.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 98 | 98 | $37,436 | $13,568 | 36.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 37 | 141 | $34,968 | $13,089 | 37.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 171 | 205 | $39,770 | $10,186 | 25.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 23 | 29 | $8,845 | $2,236 | 25.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 36 | $5,868 | $2,180 | 37.2% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Facility | 2023 | 19 | 19 | $72,501 | $1,150 | 1.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 359 | 1,235 | $376,675 | $92,487 | 24.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 106 | 231 | $89,859 | $26,540 | 29.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 42 | 143 | $35,464 | $11,418 | 32.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 75 | 75 | $28,650 | $10,677 | 37.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 51 | 104 | $31,720 | $10,183 | 32.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 93 | 98 | $19,012 | $5,083 | 26.7% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 16 | 33 | $18,777 | $3,691 | 19.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 16 | 44 | $7,172 | $2,425 | 33.8% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Facility | 2022 | 29 | 29 | $11,600 | $1,790 | 15.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 11 | 11 | $5,027 | $1,738 | 34.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 336 | 1,171 | $357,155 | $90,936 | 25.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 137 | 457 | $177,773 | $54,074 | 30.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 75 | 297 | $90,585 | $29,028 | 32.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 41 | 138 | $53,682 | $20,423 | 38.0% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 22 | 158 | $89,902 | $18,631 | 20.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 94 | 94 | $35,908 | $13,840 | 38.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 50 | 148 | $36,704 | $12,301 | 33.5% |
About Dr. Alan Thomas, MD
Dr. Alan Thomas, MD is a Hematology & Oncology healthcare provider based in Missoula, Montana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548297468.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alan Thomas, MD has received a total of $2,008 in payments from pharmaceutical and medical device companies, with $188.32 received in 2024. These payments were reported across 31 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,701).
As a Medicare-enrolled provider, Thomas has provided services to 3,084 Medicare beneficiaries, totaling 8,885 services with total Medicare billing of $716,369. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Missoula, MT
- Active Since 06/27/2006
- Last Updated 06/15/2023
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1548297468
Products in Payments
- IMBRUVICA (Drug) $391.63
- Imbruvica (Drug) $289.28
- Pomalyst (Drug) $210.60
- Soliris (Drug) $150.00
- XPOVIO (Drug) $128.18
- Kyprolis (Biological) $120.00
- Da Vinci Surgical System (Device) $100.30
- Epkinly (Drug) $88.33
- TECVAYLI (Biological) $79.73
- Perjeta (Biological) $72.76
- DARZALEX (Biological) $62.50
- Stivarga (Drug) $38.47
- BLENREP (Biological) $31.99
- JAKAFI (Drug) $31.14
- SPRYCEL (Drug) $23.87
- Kyprolis (Drug) $22.96
- SOLIRIS (Drug) $22.67
- Blincyto (Biological) $18.92
- Rubraca (Drug) $10.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Missoula
Michael Snyder, Md, MD
Hematology & Oncology — Payments: $1,110
Hematology & Oncology $1,110
Dr. Sarah Scott, Md, MD
Hematology & Oncology — Payments: $193.94
Hematology & Oncology $193.94
Patrick Beatty, Md, MD
Hematology & Oncology — Payments: $10.75
Hematology & Oncology $10.75
Linda Ries, Md, MD
Hematology & Oncology
Hematology & Oncology
Stephen Speckart, Md, MD
Hematology & Oncology
Hematology & Oncology
John Trauscht, Md, MD
Hematology & Oncology
Hematology & Oncology